Chibaatar Enkhmurun, Watanabe Keita, Okamoto Naomichi, Orkhonselenge Nasanbadrakh, Natsuyama Tomoya, Hayakawa Gaku, Ikenouchi Atsuko, Kakeda Shingo, Yoshimura Reiji
Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan.
Open Innovation Institute, Kyoto University, Kyoto, Japan.
Front Psychiatry. 2023 Mar 22;14:1151551. doi: 10.3389/fpsyt.2023.1151551. eCollection 2023.
Despite the previous inconsistent findings of structural and functional abnormalities of the thalamus in patients with major depressive disorder (MDD), the disruption of the thalamic nuclei in the pathophysiology of this disorder has not yet been adequately studied. Therefore, we investigated the volumetric changes of thalamic subregions and their nuclei in drug-naïve, first-episode MDD patients. We also investigated the association between HAM-D scores, a clinical scale frequently used to evaluate the severity of depression and thalamic nuclei volumes in MDD patients.
This study included 76 drug-naïve MDD patients and an equal number of healthy subjects. Magnetic resonance imaging (MRI) data were obtained using a 3T MR system and thalamic nuclei volumes were evaluated using FreeSurfer ver.7.11. The volumetric differences were compared by one-way analysis of covariance (ANCOVA) and to ensure that effects were not accounted for by other factors, age, sex, and ETICV variables were included as covariates.
We observed significant volume reductions of the left whole thalamus ( < 0.003) and several thalamic nuclei mostly on the left side in the MDD group compared with healthy controls (HCs). Furthermore, we have revealed weak negative correlations between several thalamic nuclei volumes and HAM-D total and subscale scores.
This is the first research study to investigate alterations of the various thalamic nuclei volumes in MDD patients compared with HCs. Moreover, we first analyzed the association between individual thalamic nuclei volumes and HAM-D subscale scores. Though our study may be restricted at certain levels, especially by the demographic difference between the two groups, they possibly contribute at a preliminary level to understanding the thalamic structural changes at its subregions in patients with drug-naïve, first-episode MDD.
尽管先前关于重度抑郁症(MDD)患者丘脑结构和功能异常的研究结果并不一致,但该疾病病理生理学中丘脑核团的破坏尚未得到充分研究。因此,我们调查了未服用过药物的首发MDD患者丘脑亚区域及其核团的体积变化。我们还研究了汉密尔顿抑郁量表(HAM-D)评分(一种常用于评估抑郁症严重程度的临床量表)与MDD患者丘脑核团体积之间的关联。
本研究纳入了76名未服用过药物的MDD患者和同等数量的健康受试者。使用3T磁共振成像(MRI)系统获取数据,并使用FreeSurfer ver.7.11评估丘脑核团体积。通过单因素协方差分析(ANCOVA)比较体积差异,并纳入年龄、性别和全脑颅内体积(ETICV)变量作为协变量,以确保其他因素不会影响结果。
与健康对照组(HCs)相比,我们观察到MDD组左侧整个丘脑体积显著减小(<0.003),并且几个丘脑核团大多在左侧体积减小。此外,我们还发现几个丘脑核团体积与HAM-D总分及各子量表评分之间存在微弱的负相关。
这是第一项研究MDD患者与HCs相比各种丘脑核团体积变化的研究。此外,我们首次分析了单个丘脑核团体积与HAM-D子量表评分之间的关联。尽管我们的研究可能在某些方面受到限制,特别是两组之间的人口统计学差异,但它们可能在初步层面上有助于理解未服用过药物的首发MDD患者丘脑亚区域的结构变化。